Oncology and Genetic Testing: Obstacles and Successes
Industry experts discuss obstacles and successes.
Read MorePosted by Judy O'Rourke | Mar 27, 2013 | Cancer, Miscellaneous, Pancreatic |
Industry experts discuss obstacles and successes.
Read MorePosted by Judy O'Rourke | Mar 27, 2013 | Biochemicals & Chemical Reagents, Cancer |
The company aims to further enhance confidence in a patient’s diagnosis, especially in cases of discriminating lung SqCC versus ADC, where a correct diagnosis is critical for therapeutic direction.
Read MorePosted by Judy O'Rourke | Mar 25, 2013 | Cancer, Miscellaneous, Research |
Researchers raise alarm about loss of individual genomic liberty due to gene patents that may impact the era of personalized medicine.
Read MorePosted by Judy O'Rourke | Feb 28, 2013 | Information Technology, Lab Automation |
Discover new products on the market.
Read MorePosted by Judy O'Rourke | Feb 26, 2013 | Cancer, Miscellaneous |
Including p63 in Biocare’s lung, prostate, and breast panels empowers its Multiplex IHC platform to aid pathologists in making critical decisions.
Read More